Melius Pharma
PrivateLast Round
Series A
May 3, 2022
Est. Valuation
$4.66M
Total Funding Raised
$1.82M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Melius Pharma operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a Series A round in May 2022.
Melius Pharma is a Swedish clinical-stage pharmaceutical company developing a therapy for Th2-associated refractory chronic cough (RCC).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melius Pharma Comparables
Compare Melius Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seyltx, Inc. | 83% | |
| Algernon Health Inc. | 80% | |
| NeRRe Therapeutics | 79% |
For institutional investors. Book with your work email.
Melius Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Melius Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fåhraeus Startup and Growth | Series A |
| Linc AB | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 35% MoM.
- Jan 19, 2026
Monthly visitors increased 58% MoM.
For institutional investors. Book with your work email.
Melius Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Melius Pharma's valuation, stock price, and market status.
Is Melius Pharma a public or private company?
Melius Pharma is a private company.
What is the current stock price of Melius Pharma?
Melius Pharma is a private company, so its shares have no public market price. Caplight tracks Melius Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Melius Pharma worth (valuation)?
Melius Pharma's valuation is estimated at $4.7M based on funding round data.
Can I buy Melius Pharma stock?
Melius Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Melius Pharma's last funding round?
Melius Pharma's most recent funding round was Series A on May 3, 2022.
Who are the main investors in Melius Pharma?
Key investors in Melius Pharma include Fåhraeus Startup and Growth, Linc AB.
Will Melius Pharma IPO soon?
No public IPO plans have been announced for Melius Pharma.
How can I track Melius Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Melius Pharma's shares on secondary markets.